Maxim Group set a $3.00 price target on Biostage Inc (NASDAQ:BSTG) in a report released on Friday. The firm currently has a a buy rating on the stock.
Biostage (NASDAQ:BSTG) opened at 0.9059 on Friday. The company’s market capitalization is $15.50 million. The stock’s 50 day moving average price is $1.04 and its 200-day moving average price is $1.33. Biostage has a 12 month low of $0.53 and a 12 month high of $3.47.
Biostage (NASDAQ:BSTG) last issued its earnings results on Thursday, August 11th. The company reported ($0.17) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.04. On average, equities research analysts predict that Biostage will post ($0.86) EPS for the current fiscal year.
Biostage Company Profile